Azenta Shares Surge 20.8% Following Financial Report Release

On Wednesday, Azenta presented its results for the fourth quarter of the 2026 fiscal year. The company's revenue increased by 5% year-over-year to $167 million, while adjusted net profit reached $12.3 million, or $0.28 per share.

Revenue from the sample management solutions segment grew by 9% to $94 million. The multiomics division, which analyzes multiple types of molecules simultaneously, generated $73 million in revenue, showing almost no change. Analysts had expected revenue slightly above $160 million and adjusted profit of $0.12 per share.

For the 2027 fiscal year, Azenta forecasts revenue in the range of $648–660 million. The company also expects adjusted EBITDA margin growth of 200–250 basis points compared to the 2026 result. No net profit forecast was provided.

Azenta specializes in automated sample storage for the medical industry. The original material also attributes the rise in stock prices to expectations of margin expansion, the company's financial position, and the potential of this segment—this is the author's assessment, not Azenta's forecast.